A Randomized, Controlled Trial of mg of Liraglutide in Weight

liraglutide Liraglutide is a biological medicine Biological medicines must be prescribed and dispensed by brand name, see Biological medicines and Biosimilar medicines,

The managed access of liraglutide includes two phases of reimbursement approval Phase 1 reimbursement support is for an initial duration of six liraglutide Liraglutide is a GLP-1 analog used in the management of type 2 diabetes mellitus and prevention of cardiovascular complications associated with diabetes